"潍坊高新区医养健康产业起步较早，基础良好、优势明显，入选全国生物医药产业百强园区，生物医药产业园入选山东省行业唯一的生物医药产业特色 小镇，建有9个国家级、18个省级研发平台。"高新区党工委书记、管委会主任赵文君说，目前，高新区已聚集沃华医药（002107）、华辰制药、海王医 药、诺一迈尔等骨干企业30余家。潍坊高新区始终坚持"每个人每个单位都是高新区的营商环境"理念，城市活力旺盛、发展后劲充足，诚挚邀请企业家朋 友到潍坊高新区加强交流、投资兴业。 会上，与会专家分别作主旨演讲，有关企业推介了产业项目。会后，意向企业开展了对口洽谈。 "医养健康产业作为重要新兴绿色低碳朝阳产业，是民生改善和经济发展的重要契合点，也是两岸深化合作、共促民生福祉的重要纽带。"潍坊市委常委、 副市长吕珊珊表示。当前，潍坊市正加快建设实力强品质优生活美的更好潍坊，全力打造山东医学新高地，发展医养健康产业基础坚实、潜力巨大、前景 广阔。本次产业对接会为促进两岸医养健康产业交流合作搭建了重要的平台，提供了难得的机遇，希望广大与会嘉宾更多关注潍坊、支持潍坊、投资潍 坊，促进更多创新成果在潍坊转化应用，推动更多项目在潍坊落地达效。 齐鲁晚报 ...

Core Viewpoint - The company has announced its 2025 mid-year profit distribution plan, which was approved during the third extraordinary shareholders' meeting held on August 12, 2025 [1] Summary by Sections Shareholders' Meeting Approval - The profit distribution plan was approved at the third extraordinary shareholders' meeting on August 12, 2025 [1] Cash Dividend Distribution - The company will distribute a cash dividend of 1.20 yuan per 10 shares, totaling 69,265,152 yuan (including tax) [2] - No bonus shares will be issued, and no capital reserves will be converted into share capital [2] - The total dividend amount will be adjusted if there are changes in the total share capital before the record date [2] Implementation Details - The cash dividend distribution is based on a total share capital of 577,209,600 shares [2] - The distribution plan is consistent with the profit distribution plan approved by the shareholders' meeting [2] - The implementation of the plan will occur within two months of the shareholders' meeting approval [2] Key Dates - The record date for the dividend distribution is September 10, 2025, and the ex-dividend date is September 11, 2025 [3] Distribution Method - Cash dividends will be directly credited to the accounts of A-share shareholders through their securities companies on the ex-dividend date [4] - The company will handle the distribution for specific shareholders as listed [4] Consultation Information - Contact details for inquiries are provided, including the address and phone number [4]

Group 1 - The company announced a cash dividend distribution plan for the first half of 2025, proposing a payout of 1.20 yuan (including tax) for every 10 shares held by shareholders [2] - The record date for the dividend distribution is set for September 10, 2025, and the ex-dividend date will be September 11, 2025 [2]

Group 1 - The company announced a cash dividend distribution plan for the first half of 2025, proposing a payout of 1.20 yuan (including tax) for every 10 shares held [1] - The total number of shares used as the basis for the distribution is 577,209,600 [1] - The record date for the dividend distribution is set for September 10, 2025, with the ex-dividend date on September 11, 2025 [1]

证券代码：002107 证券简称：沃华医药 公告编号：2025-039 山东沃华医药科技股份有限公司 2025 年中期权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 山东沃华医药科技股份有限公司（以下简称公司）2025 年中期 权益分派方案已获 2025 年 8 月 12 日召开的公司 2025 年第三次临时 股东会审议通过，现将权益分派事宜公告如下： 一、股东会审议通过权益分派方案情况 （一）2025 年 8 月 12 日，公司 2025 年第三次临时股东会审议 通过了《关于 2025 年中期利润分配预案》（以下简称利润分配方案）。 根据该方案，公司以现有总股本 577,209,600 股为基数，向全体股东 每10股派发现金红利1.20元（含税），共计派发现金红利69,265,152.00 元（含税），不送红股，不以公积金转增股本。上述利润分配方案披 露后至权益分派实施公告确定的股权登记日前，公司总股本发生变动 的，公司将按照每股分红金额不变的原则，相应调整分红总额。 （二）自利润分配方案披露至实施期间，公司股本总额未发生变 化。 （三）本 ...

Core Viewpoint - Wowo Pharmaceutical (002107.SZ) announced a cash dividend distribution plan for the mid-term of 2025, indicating a commitment to returning value to shareholders [1] Group 1 - The company will distribute a cash dividend of 1.20 yuan (including tax) for every 10 shares held, based on a total of 577,209,600 shares [1] - The record date for the dividend distribution is set for September 10, 2025, and the ex-dividend date is September 11, 2025 [1]

Market Overview - The Shanghai Composite Index closed at 3800.35 points, with a decline of 1.76% [1] - The total trading volume of A-shares reached 31,977.88 billion yuan [1] Technical Analysis - A total of 150 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Hengyu Xintong: 5-day MA at 76.38 yuan, 10-day MA at 77.37 yuan, difference of -1.28% [1] - ST Huayang: 5-day MA at 11.72 yuan, 10-day MA at 11.84 yuan, difference of -0.94% [1] - Wohua Pharmaceutical: 5-day MA at 6.96 yuan, 10-day MA at 7.02 yuan, difference of -0.78% [1] Individual Stock Performance - Hengyu Xintong: Today's decline of 5.98%, with a turnover rate of 14.00% [1] - ST Huayang: Today's decline of 5.04%, with a turnover rate of 0.09% [1] - Wohua Pharmaceutical: Today's decline of 3.03%, with a turnover rate of 3.42% [1] - Other notable declines include: - Longshen: -3.62% [1] - Zhuhua Design: -5.51% [1] - Dadi Ocean: -7.20% [1] Additional Stock Data - The following stocks also showed significant declines: - Kexin Technology: -2.56% [1] - Chenxi: -5.85% [1] - Yuxing Co.: -7.53% [1] - Yingjian Technology: -6.08% [1] - Senhe Co.: -6.08% [1] - Huayuan Holdings: -3.42% [1]

Market Overview - The Shanghai Composite Index is at 3868.00 points with a slight decline of -0.01% as of 10:29 AM [1] - The total trading volume of A-shares is 12,533.34 billion yuan [1] Stocks with Death Cross - A total of 54 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Hengyu Xintong: 5-day MA at 76.46 yuan, 10-day MA at 77.41 yuan, difference of -1.23% [1] - ST Huayang: 5-day MA at 11.72 yuan, 10-day MA at 11.84 yuan, difference of -0.94% [1] - Wohua Pharmaceutical: 5-day MA at 6.99 yuan, 10-day MA at 7.03 yuan, difference of -0.60% [1] Additional Stocks with Death Cross - Other stocks showing a death cross include: - Longshen Rongfa: 5-day MA at 10.88 yuan, 10-day MA at 10.95 yuan, difference of -0.56% [1] - Dadi Ocean: 5-day MA at 31.63 yuan, 10-day MA at 31.76 yuan, difference of -0.39% [1] - Morning Star Aviation: 5-day MA at 22.66 yuan, 10-day MA at 22.75 yuan, difference of -0.36% [1] Performance of Selected Stocks - Performance metrics for selected stocks include: - Hengyu Xintong: Today's change of -5.48% with a turnover rate of 8.19% [1] - ST Huayang: Today's change of -5.04% with a turnover rate of 0.08% [1] - Wohua Pharmaceutical: Today's change of -1.15% with a turnover rate of 1.39% [1] Summary of Other Stocks - Additional stocks with notable performance include: - Hanhai Environmental: Today's change of -3.51% with a turnover rate of 0.98% [1] - Sen Tai: Today's change of -4.05% with a turnover rate of 2.39% [1] - Huayuan Holdings: Today's change of -0.68% with a turnover rate of 1.21% [1]

Market Overview - The Shanghai Composite Index closed at 3881.07 points, with a change of +0.33% [1] - The total trading volume of A-shares reached 1,746.291 billion yuan [1] Technical Analysis - A total of 46 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Hengyu Xintong: 5-day MA at 76.55 yuan, 10-day MA at 77.45 yuan, difference of -1.17% [1] - ST Huayang: 5-day MA at 11.72 yuan, 10-day MA at 11.84 yuan, difference of -0.94% [1] - Wohua Pharmaceutical: 5-day MA at 6.99 yuan, 10-day MA at 7.03 yuan, difference of -0.58% [1] Stock Performance - Hengyu Xintong: Today's change -4.90%, turnover rate 9.91% [1] - ST Huayang: Today's change -5.04%, turnover rate 0.08% [1] - Wohua Pharmaceutical: Today's change -1.01%, turnover rate 1.87% [1] - Other notable stocks with negative performance include: - Longshen Rongfa: -0.65% [1] - Dadi Ocean: -4.27% [1] - Baili Technology: -1.82% [1] - Chengxi Aviation: -3.21% [1] - Dengkang Oral: -0.97% [1] - Sentai Co., Ltd.: -3.62% [1] - Huayuan Holdings: -0.46% [1] - Yingjian Technology: -2.78% [1] - Linhai Co., Ltd.: -1.55% [1] - Rundou Co., Ltd.: -1.88% [1] - Shengyuan Biotech: -3.27% [1] - Keshan Co., Ltd.: +0.03% [1] - Xiangshan Co., Ltd.: +0.58% [1] Additional Observations - The stocks with the largest percentage drop in their 5-day moving averages compared to their 10-day moving averages indicate potential bearish trends [1][2] - The overall market sentiment appears cautious, with several stocks showing significant declines in both price and trading volume [1][2]

Group 1 - The core viewpoint of the news highlights the financial performance and stock activity of Wohuah Pharmaceutical, indicating a modest increase in stock price and significant growth in net profit [1][3] - As of August 25, 2025, Wohuah Pharmaceutical's stock closed at 7.01 yuan, with a trading volume of 168,500 hands and a transaction amount of 118 million yuan [1] - The company reported total revenue of 425 million yuan for the first half of 2025, reflecting a year-on-year growth of 7.64%, while net profit attributable to shareholders reached 44.68 million yuan, up 303.16% [1] Group 2 - The company has a liquidity ratio of 2.343 and a quick ratio of 1.957, indicating strong short-term financial health [1] - Wohuah Pharmaceutical has made investments in five companies and participated in 5,000 bidding projects, showcasing its active engagement in the market [2] - The company holds 25 trademark registrations and 54 patents, along with 31 administrative licenses, reflecting its commitment to innovation and compliance [2]